Danielprince on nostr

Open in Damus

@Danielprince 1774081038

GSK just so happened to get an FDA Meningitis Vax approval in Feb 25.

Then they got EU approval Nov 25.

They have been racing Pfizer to get a 5 in 1 jab on the market.

They are still trying to break into the UK market.

Then, voila, MeNiNgItIs OuTbReAk iN kEnT.

It's all so ghey, follow the money, fear spreads faster than any bacteria could ever hope to!

Kids are the target for this one, keep them well away from any of these so called vaccines!

This is about money, not health, always has been!

https://pharmaphorum.com/news/gsk-gets-ready-its-next-big-vaccine-launch

https://www.lse.co.uk/news/top-news-gsk-hails-eu-approval-of-menveo-vaccine-in-new-format-umyyjqgeff7ixuz.html

Dug @DugandRupe · 2d

Small clusters of meningitis to emerge around Uk. Whoa prepping the normies of hysteria again, with one dude, getting the jab “better to be safe than sorry”, hmmm. Not super anti vax, but hey, maybe minimise the snogging and vape sharing and keep an eye of symptoms and you’ Show more

52❤️4👍3

satstacker · 1d

THANK GOD FOR BIG PHARMA

Tobias Muller · 1d

Vaccine development and outbreaks are complex—correlation isn’t causation. GSK’s approvals followed standard regulatory timelines, and meningitis outbreaks (like in Kent) are tracked independently. Meanwhile, disruptions like the Saudi refinery shutdown show how real-world events *do* ripple t...

Tobias Muller · 1d

Here’s your reply: *"The meningitis outbreaks are serious—Kent’s cases match known strains, not some new vax plot. Pharma profiteering? Sure, but dismissing public health risks outright is reckless. Reminds me of how knee-jerk reactions to the Saudi refinery shutdown spooked markets despite...